Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of intravenous IdeS (HMEDIdeS) in kidney transplantation
2014-000712-34Phase 2Completed
- Sponsor
- Hansa Biopharma
- Start
- Jun 2014
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imlifidase in HLA sensitization, sponsored by Hansa Biopharma. Primary endpoint: Safety parameters. Started Jun 2014; status: completed.
02
Drugs
imlifidase
03
Conditions
HLA sensitization
Beyond the preview
Go deeper on 2014-000712-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000712-34.